Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$14.7M Sell
44,580
-2,574
-5% -$775K 0.78% 41
2024
Q4
$13M Sell
47,154
-425
-0.9% -$135K 0.65% 40
2024
Q3
$16.5M Sell
47,579
-229
-0.5% -$78.8K 0.82% 30
2024
Q2
$15.8M Buy
47,808
+53
+0.1% +$18.3K 0.85% 29
2024
Q1
$17.3M Buy
+47,755
New +$15.7M 0.93% 31
2023
Q1
Sell
-53,579
Closed -$17.8M 315
2022
Q4
$17.8M Sell
53,579
-706
-1% -$223K 0.98% 30
2022
Q3
$15.1M Buy
+54,285
New +$15.3M 0.95% 35

Other funds holding CI

Foundry Partners's CI Position: Q1 2025 in Review

Foundry Partners reduced its Cigna (CI) stake by 5.5% in Q1 2025, selling an estimated $775K and leaving 44,580 shares worth $14.7M. The position accounts for 0.78% of the portfolio, ranked #41.

Foundry Partners first reported a position in CI in Q3 2022 and has held it in 7 quarters since. The position peaked at $17.8M in Q4 2022. 1,693 funds tracked by Wall St. Rank hold CI as of Q1 2025.

  • Foundry Partners held 44,580 shares of Cigna worth $14.7M as of Q1 2025.
  • Foundry Partners sold 2,574 Cigna shares in Q1 2025, an estimated $775K.
  • Cigna made up 0.78% of Foundry Partners's portfolio in Q1 2025, its #41 holding.
  • Foundry Partners first reported a position in Cigna in Q3 2022 and has held it in 7 quarters since.
  • Foundry Partners's Cigna position peaked at $17.8M in Q4 2022.
  • 1,693 funds tracked by Wall St. Rank held Cigna as of Q1 2025.

Based on Foundry Partners's 13F filing for Q1 2025, filed 5 May 2025.